Skip to content
This project is no longer being actively updated. Listings below are accurate as of their last-verified date, but no new opportunities are being added.Read more →
💰grantIndiaNew

Genesis by IKP — Deep Science Startup Incubation (Cohort 1)

Deadline
2026-07-31
Deadline type
Fixed
Region
India
Category
Grant
Eligibility
Deep science startups at TRL 2–3 (early proof-of-concept stage). Must be incorporated as Private Limited company in India (OPC and LLP not eligible). At least 51% shareholding by Indian citizens. Sectors: Diagnostics, Biotherapeutics, Industrial Biotech, Healthtech & AI. Only 4–5 startups selected per cohort.
Remote
No
Last verified
Verified on 2026-07-03

💡 ₹30 lakh + deep hands-on mentorship for breakthrough deep science at TRL 2–3 — IKP takes 2–3% equity in exchange for 12 months of direct translation support.

Deadline31 Jul 2026 (4 days left)
Efforthigh
Eligibility summaryDeep science startups at TRL 2–3 (early proof-of-concept stage). Must be incorporated as Private Limited company in India (OPC and LLP not eligible). At least 51% shareholding by Indian citizens. Sectors: Diagnostics, Biotherapeutics, Industrial Biotech, Healthtech & AI. Only 4–5 startups selected per cohort.
Last verified2026-07-03
CategoryGrant
RegionIndia
Description

IKP Knowledge Park's (Hyderabad) structured 12-month deep science translation program for startups at TRL 2–3. Provides up to ₹30 lakhs in funding in exchange for 2–3% equity (held as CCPS), plus hands-on mentorship on IP strategy, regulatory pathway, manufacturing readiness, and investor pitch. IKP works directly with each team for the full 12 months — not through arm's-length advisors. Only 4–5 startups selected per cohort. Applications open June–July 2026, program starts September 2026. Note: this is equity-based funding, not a grant.

Tags
AIstartupIndiabiotechdeep scienceIKPhealthtechincubation

Remind me about this opportunity

No account needed. Enter your email and we'll send reminders only for this opportunity.

Frequently asked questions

Who can apply?
Deep science startups at TRL 2–3 (early proof-of-concept stage). Must be incorporated as Private Limited company in India (OPC and LLP not eligible). At least 51% shareholding by Indian citizens. Sectors: Diagnostics, Biotherapeutics, Industrial Biotech, Healthtech & AI. Only 4–5 startups selected per cohort.
Is this remote?
No, this is not listed as a remote opportunity.
Is there a hard deadline?
Yes — applications close on 2026-07-31.
🔍

Check your eligibility

Answer a few quick questions — nothing is saved, this just checks against this opportunity's stated criteria.

📬

Biweekly opportunity digest

This project is no longer being actively updated, so new subscriptions are currently closed. See /about for details.